By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Overview
This guideline by the American College of Chest Physicians aims to guide providers involved in the respiratory care of patients with neuromuscular disease (NMDs) with the understanding that variations in the patterns of respiratory muscle involvement and timing of clinical presentation and progression of NMDs occur that require an understanding of the patient’s underlying disease process before using the recommendations.
Members Only Content
Join APTA to get unlimited access to content including evidence-based research, guidance on payment changes, and other resources to help you thrive. Learn more about membership benefits.
Already a member? Log in
Date: March 13, 2023
Contact: practice@apta.org
Content Type: CPG
Amyotrophic Lateral Sclerosis, Lung Conditions, Muscular Dystrophy, Respiratory Conditions, Myasthenia Gravis
Young Adult (19-24), Adult (25-44), Middle Aged (45-64), Aged (65+), 80 and over (80+)
Khan A, Frazer-Green L, Amin R, et al; American College of Chest Physicians, Canadian Thoracic Society
You Might Also Like...
Clinical Summary
Amyotrophic Lateral Sclerosis (ALS)Feb 6, 2024
PTs play a vital role as part of a multidisciplinary team to care for persons with ALS across the spectrum of the condition.
CPG
COVID-19 Rapid Guideline: Managing Symptoms (Including at the End of Life) in the Community [NG191]Mar 23, 2021
Recommendations for managing COVID‑19 symptoms for patients in the community -- babies, children, young people, and adults in all care settings, including
CPG
Motor Neurone Disease: Assessment and Management [NG42]Jul 23, 2019
Recommendations to improve care from the time of diagnosis, and covers information and support, organisation of care, managing symptoms and preparing for